These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 11377305)

  • 1. Correlation between biopsy and radical cystectomy in assessing grade and depth of invasion in bladder urothelial carcinoma.
    Chang BS; Kim HL; Yang XJ; Steinberg GD
    Urology; 2001 Jun; 57(6):1063-6; discussion 1066-7. PubMed ID: 11377305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of urothelial carcinoma ambiguous for muscularis propria invasion on initial transurethral resection of bladder tumor.
    Hassan O; Murati Amador B; Lombardo KA; Salles D; Cuello F; Marwaha AS; Daniels MJ; Kates M; Bivalacqua TJ; Matoso A
    World J Urol; 2020 Feb; 38(2):389-395. PubMed ID: 31030230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphovascular invasion of urothelial cancer in matched transurethral bladder tumor resection and radical cystectomy specimens.
    Kunju LP; You L; Zhang Y; Daignault S; Montie JE; Lee CT
    J Urol; 2008 Nov; 180(5):1928-32; discussion 1932. PubMed ID: 18801529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of transurethral resection of the bladder specimens with pT1 high-grade urothelial carcinoma for the predictor features of muscularis propria invasion on radical cystectomy specimens.
    Kir GG; Girgin RBB; Soylemez Söylemez TT; Melemez MKK; Topal CSS; Turan T; Caskurlu Çaşkurlu T; Yıldırım AA
    Ann Diagn Pathol; 2018 Dec; 37():25-29. PubMed ID: 30236545
    [No Abstract]   [Full Text] [Related]  

  • 5. Analysis of T1 Bladder Cancer on Biopsy and Transurethral Resection Specimens: Comparison and Ranking of T1 Quantification Approaches to Predict Progression to Muscularis Propria Invasion.
    Leivo MZ; Sahoo D; Hamilton Z; Mirsadraei L; Shabaik A; Parsons JK; Kader AK; Derweesh I; Kane C; Hansel DE
    Am J Surg Pathol; 2018 Jan; 42(1):e1-e10. PubMed ID: 29076872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of second opinion pathology in the definitive management of patients with bladder carcinoma.
    Coblentz TR; Mills SE; Theodorescu D
    Cancer; 2001 Apr; 91(7):1284-90. PubMed ID: 11283928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Grading and staging of bladder carcinoma in transurethral resection specimens. Correlation with 105 matched cystectomy specimens.
    Cheng L; Neumann RM; Weaver AL; Cheville JC; Leibovich BC; Ramnani DM; Scherer BG; Nehra A; Zincke H; Bostwick DG
    Am J Clin Pathol; 2000 Feb; 113(2):275-9. PubMed ID: 10664630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive value of combined immunohistochemical markers in patients with pT1 urothelial carcinoma at radical cystectomy.
    Shariat SF; Bolenz C; Godoy G; Fradet Y; Ashfaq R; Karakiewicz PI; Isbarn H; Jeldres C; Rigaud J; Sagalowsky AI; Lotan Y
    J Urol; 2009 Jul; 182(1):78-84; discussion 84. PubMed ID: 19447418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Radical cystectomy in the treatment of bladder cancer always in due time?].
    May M; Braun KP; Richter W; Helke C; Vogler H; Hoschke B; Siegsmund M
    Urologe A; 2007 Aug; 46(8):913-9. PubMed ID: 17676301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pathohistological comparison of biopsy specimens with all-layer cystectomy specimens in bladder cancer].
    Miyamoto K; Higaki Y; Saitoh T; Imamura K; Sugiyama Y
    Hinyokika Kiyo; 1989 Oct; 35(10):1687-91. PubMed ID: 2610177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathologic prognostic parameters in bladder urothelial biopsy, transurethral resection, and cystectomy specimens.
    Lapham RL; Grignon D; Ro JY
    Semin Diagn Pathol; 1997 May; 14(2):109-22. PubMed ID: 9179972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The value of pathologic factors in predicting cancer-specific survival among patients treated with radical cystectomy for transitional cell carcinoma of the bladder and prostate.
    Frazier HA; Robertson JE; Dodge RK; Paulson DF
    Cancer; 1993 Jun; 71(12):3993-4001. PubMed ID: 8508365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic interest in discriminating muscularis mucosa invasion (T1a vs T1b) in nonmuscle invasive bladder carcinoma: French national multicenter study with central pathology review.
    Rouprêt M; Seisen T; Compérat E; Larré S; Mazerolles C; Gobet F; Fetissof F; Fromont G; Safsaf A; d'Arcier BF; Celhay O; Validire P; Rozet F; Irani J; Soulié M; Pfister C;
    J Urol; 2013 Jun; 189(6):2069-76. PubMed ID: 23201497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Challenges in Pathologic Staging of Bladder Cancer: Proposals for Fresh Approaches of Assessing Pathologic Stage in Light of Recent Studies and Observations Pertaining to Bladder Histoanatomic Variances.
    Paner GP; Montironi R; Amin MB
    Adv Anat Pathol; 2017 May; 24(3):113-127. PubMed ID: 28398951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-muscle invasive high grade urothelial carcinoma of the bladder. Which factors can influence understaging at the time of radical cystectomy?
    Minardi D; Milanese G; Parri G; Lacetera V; Muzzonigro G
    Arch Ital Urol Androl; 2016 Mar; 88(1):13-6. PubMed ID: 27072170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of patients with clinical T1 grade 3 urothelial cell bladder carcinoma treated with radical cystectomy.
    Gupta A; Lotan Y; Bastian PJ; Palapattu GS; Karakiewicz PI; Raj GV; Schoenberg MP; Lerner SP; Sagalowsky AI; Shariat SF;
    Urology; 2008 Feb; 71(2):302-7. PubMed ID: 18308108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. International Society of Urological Pathology (ISUP) Consensus Conference on Current Issues in Bladder Cancer. Working Group 2: Grading of Mixed Grade, Invasive Urothelial Carcinoma Including Histologic Subtypes and Divergent Differentiations, and Non-Urothelial Carcinomas.
    Paner GP; Kamat A; Netto GJ; Samaratunga H; Varma M; Bubendorf L; van der Kwast TH; Cheng L;
    Am J Surg Pathol; 2024 Jan; 48(1):e11-e23. PubMed ID: 37382156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion].
    Słojewski M
    Ann Acad Med Stetin; 2000; 46():217-29. PubMed ID: 11712306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Substaging of T1 bladder carcinoma based on the depth of invasion as measured by micrometer: A new proposal.
    Cheng L; Weaver AL; Neumann RM; Scherer BG; Bostwick DG
    Cancer; 1999 Sep; 86(6):1035-43. PubMed ID: 10491531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of the time period between diagnosis of muscle invasion and radical cystectomy with regard to the prognosis of transitional cell carcinoma of the urothelium in the bladder.
    May M; Nitzke T; Helke C; Vogler H; Hoschke B
    Scand J Urol Nephrol; 2004; 38(3):231-5. PubMed ID: 15204377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.